+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Sulindac in ankylosing spondylitis. Double-blind evaluation of sulindac and indomethacin



Sulindac in ankylosing spondylitis. Double-blind evaluation of sulindac and indomethacin



JAMA 242(17): 1885-1886



Ankylosing spondylitis affects about 1% of the population. In the past, evaluation of therapy in the management of this disease has been hampered by the lack of availability of objective criteria for following the condition. By using recently developed measurements of spinal mobility and other variables we have compared sulindac, a recently introduced nonsteroidal antiinflammatory drug, and indomethacin in a double-blind six-month parallel study of 30 patients. Sulindac and indomethacin have comparable efficacy and tolerance. Advantages of sulindac include a twice-a-day dose regimen.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 041487323

Download citation: RISBibTeXText

PMID: 480622


Related references

Sulindac and indomethacin in the treatment of ankylosing spondylitis: a double-blind cross-over study. Rheumatology and Rehabilitation 19(3): 189-192, 1980

A double-blind study comparing sulindac with indomethacin in rheumatoid arthritis. Scandinavian Journal of Rheumatology. Supplement 37: 1-6, 1980

A Double-blind Study Comparing Sulindac with Indomethacin in Rheumatoid Arthritis. Scandinavian Journal of Rheumatology 10(S37): 1-6, 1981

A double blind multicenter study of sulindac once daily versus sulindac twice daily in osteoarthritis of the knee. Current Therapeutic Research 41(5): 692-705, 1987

A double blind multicenter study of sulindac once daily versus sulindac twice daily in rheumatoid arthritis. Current Therapeutic Research 41(5): 679-691, 1987

The proapoptotic effects of sulindac, sulindac sulfone and indomethacin are mediated by nucleolar translocation of the RelAp65 subunit of NF-kappa B. Oncogene 27(18): 2648-2655, 2008

Sulindac in ankylosing spondylitis. Harefuah 94(10): 320-321, 1978

Sulindac and indomethacin suppress the diuretic action of furosemide in patients with cirrhosis and ascites: evidence that sulindac affects renal prostaglandins. American Journal of Kidney Diseases 6(4): 217-221, 1985

Sulindac and its metabolites sulindac sulfide and sulindac sulfone induce apoptosis in human cervical cancer cells. Proceedings of the American Association for Cancer Research Annual Meeting 39: 196, 1998

Sulindac and its metabolites: sulindac sulfide and sulindac sulfone enhance cytotoxic effects of arsenic trioxide on leukemic cell lines. Toxicology in Vitro 25(5): 1075-1084, 2011

Gene expression and cell cycle analysis of HT29 human colon cancer cells, exposed to celecoxib, indomethacin, sulindac sulfide and sulindac sulfone. Proceedings of the American Association for Cancer Research Annual Meeting 44: 798, 2003

A comparative study of diclofenac and sulindac in ankylosing spondylitis. Rheumatology and Rehabilitation 19(3): 193-198, 1980

Inhibition of UVB-induced AP-1 activation by sulindac, sulindac sulfide, and sulindac sulfone. Proceedings of the American Association for Cancer Research Annual Meeting (41): 494, 2000

A double-blind randomized study of fetal side effects during and after the short-term maternal administration of indomethacin, sulindac, and nimesulide for the treatment of preterm labor. American Journal of Obstetrics & Gynecology 188(4): 1046-1051, 2003

Placental transfer of sulindac, sulindac sulfide, and indomethacin in a human placental perfusion model. American Journal of Obstetrics & Gynecology 180(1 Part 1): 174-180, 1999